Measure 8 Venture Partners
Overview
Measure 8 Venture Partners is a venture capital firm that focuses on investments in the cannabis industry across the United States. The firm's private equity arm primarily focuses on seed and early-stage investments.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Kanna Medics GmbH | May 2022 | Seed | Co-investor |
| Bloomwell Group | Feb 2023 | Growth Equity | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Measure 8 Venture Partners based?
Measure 8 Venture Partners is headquartered in New York City, New York, United States.
When was Measure 8 Venture Partners founded?
Measure 8 Venture Partners was founded in 2017.
How many portfolio companies does Measure 8 Venture Partners have?
Measure 8 Venture Partners has 2 portfolio companies in Caplight's dataset.
What are some companies in Measure 8 Venture Partners's portfolio?
Portfolio companies visible on Caplight include Kanna Medics GmbH, Bloomwell Group.
What was Measure 8 Venture Partners's most recent investment shown here?
Measure 8 Venture Partners's most recent investment in this portfolio sample was in Bloomwell Group in 2023.
What sectors does Measure 8 Venture Partners focus on?
Measure 8 Venture Partners focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Enterprise Software.
What company stages does Measure 8 Venture Partners focus on?
Measure 8 Venture Partners typically invests at the Early stage.
What is Measure 8 Venture Partners's AUM?
Measure 8 Venture Partners's assets under management are estimated between $100.0M and $250.0M.